Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Nedellec

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Genetics|February 17, 2010
Fitness epistasis and constraints on adaptation in a human immunodeficiency virus type 1 protein regionJack da Silva, Mia Coetzer, Rebecca Nedellec, et al.
AIDS (London, England)|April 7, 2007
HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entryCatherine A Blish, Rebecca Nedellec, Kishorchandra Mandaliya, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 6, 2010
Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype CMia Coetzer, Rebecca Nedellec, Tonie Cilliers, et al.
Journal of Virology|January 5, 2007
Evolution of CXCR4-using human immunodeficiency virus type 1 SF162 is associated with two unique envelope mutationsYana Kiselyeva, Rebecca Nedellec, Alejandra Ramos, et al.
Plos One|July 16, 2011
Resistance to the CCR5 inhibitor 5P12-RANTES requires a difficult evolution from CCR5 to CXCR4 coreceptor useRebecca Nedellec, Mia Coetzer, Michael M Lederman, et al.
Journal of Virology|March 26, 2010
"Resistance" to PSC-RANTES revisited: two mutations in human immunodeficiency virus type 1 HIV-1 SF162 or simian-human immunodeficiency virus SHIV SF162-p3 do not confer resistanceRebecca Nedellec, Mia Coetzer, Michael M Lederman, et al.
Journal of Virology|May 18, 2007
Conserved changes in envelope function during human immunodeficiency virus type 1 coreceptor switchingCristina Pastore, Rebecca Nedellec, Alejandra Ramos, et al.
Journal of Virology|September 26, 2008
Evolution of CCR5 use before and during coreceptor switchingMia Coetzer, Rebecca Nedellec, Janelle Salkowitz, et al.
Journal of Virology|July 13, 2012
CCR5 mutations distinguish N-terminal modifications of RANTES (CCL5) with agonist versus antagonist activityWon-Tak Choi, Rebecca Nedellec, Mia Coetzer, et al.
Human Antibodies|January 27, 2005
Human monoclonal antibodies that neutralize anthrax toxin by inhibiting heptamer assemblyFei Wang, Paul Ruther, Ivy Jiang, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Genetics|February 17, 2010
Fitness epistasis and constraints on adaptation in a human immunodeficiency virus type 1 protein regionJack da Silva, Mia Coetzer, Rebecca Nedellec, et al.
AIDS (London, England)|April 7, 2007
HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entryCatherine A Blish, Rebecca Nedellec, Kishorchandra Mandaliya, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 6, 2010
Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype CMia Coetzer, Rebecca Nedellec, Tonie Cilliers, et al.
Journal of Virology|January 5, 2007
Evolution of CXCR4-using human immunodeficiency virus type 1 SF162 is associated with two unique envelope mutationsYana Kiselyeva, Rebecca Nedellec, Alejandra Ramos, et al.
Plos One|July 16, 2011
Resistance to the CCR5 inhibitor 5P12-RANTES requires a difficult evolution from CCR5 to CXCR4 coreceptor useRebecca Nedellec, Mia Coetzer, Michael M Lederman, et al.
Journal of Virology|March 26, 2010
"Resistance" to PSC-RANTES revisited: two mutations in human immunodeficiency virus type 1 HIV-1 SF162 or simian-human immunodeficiency virus SHIV SF162-p3 do not confer resistanceRebecca Nedellec, Mia Coetzer, Michael M Lederman, et al.
Journal of Virology|May 18, 2007
Conserved changes in envelope function during human immunodeficiency virus type 1 coreceptor switchingCristina Pastore, Rebecca Nedellec, Alejandra Ramos, et al.
Journal of Virology|September 26, 2008
Evolution of CCR5 use before and during coreceptor switchingMia Coetzer, Rebecca Nedellec, Janelle Salkowitz, et al.
Journal of Virology|July 13, 2012
CCR5 mutations distinguish N-terminal modifications of RANTES (CCL5) with agonist versus antagonist activityWon-Tak Choi, Rebecca Nedellec, Mia Coetzer, et al.
Human Antibodies|January 27, 2005
Human monoclonal antibodies that neutralize anthrax toxin by inhibiting heptamer assemblyFei Wang, Paul Ruther, Ivy Jiang, et al.
Pageof 4